Novartis Executive and Leadership Team

Sylvester Feddes, the Country President & Chief Executive Officer (Brazil) at Novartis, directs all pharmaceutical operations within the South American market. Feddes manages the regional strategy, ensuring that the company meets local healthcare demands through the delivery of innovative medications. By overseeing the integration of global corporate policies with regional market requirements, the Country President & Chief Executive Officer (Brazil) drives sustainable growth. This role involves leading local teams to achieve excellence in commercial performance and regulatory compliance. Sylvester Feddes maintains strong relationships with regional health authorities to facilitate the introduction of new therapeutic solutions. Through the optimization of local supply chains and marketing efforts, the Country President & Chief Executive Officer (Brazil) ensures that the organization remains a dominant force in the Brazilian pharmaceutical sector. This leadership role directly supports the global mission of the company by expanding the reach of healthcare solutions into critical emerging markets.

Michael Heo, the Chief Financial Officer, & Distributor Markets (Malaysia, South, Asia) at Novartis, manages the financial health and distribution logistics across key Asian territories. Heo architects fiscal strategies that support the expansion of pharmaceutical access in these diverse markets. By overseeing the financial performance of distributor networks, the Chief Financial Officer, & Distributor Markets (Malaysia, South, Asia) ensures that the company maintains profitability while meeting regional healthcare needs. This role involves analyzing market trends to optimize resource allocation and investment. Michael Heo drives the implementation of financial controls that enhance operational efficiency. Through the management of complex distributor relationships, the Chief Financial Officer, & Distributor Markets (Malaysia, South, Asia) ensures that the supply chain remains robust and responsive. This leadership position directly contributes to the global financial stability of the organization, enabling the continued development and distribution of innovative medications across the Asian region.

Melissa McKerracher, the Chief Financial Officer, Novartis (US) at Novartis, directs the financial planning and analysis for the North American division. McKerracher manages the capital allocation process, ensuring that the company invests effectively in research and commercial growth. By overseeing the financial reporting and compliance functions, the Chief Financial Officer, Novartis (US) maintains the integrity of the fiscal operations. This role involves collaborating with executive leadership to align financial goals with the broader strategic objectives of the organization. Melissa McKerracher drives the implementation of cost-optimization initiatives that improve the bottom line. Through the rigorous management of financial risks, the Chief Financial Officer, Novartis (US) ensures that the company remains well-positioned to navigate the competitive US pharmaceutical market. This leadership function directly supports the ability of the organization to fund the development of new healthcare solutions, ultimately driving long-term value for stakeholders and patients alike.

Keizo Miyazawa, the President (Taiwan) at Novartis, directs all pharmaceutical operations and strategic initiatives within the Taiwanese market. Miyazawa manages the local organizational structure, ensuring that the company effectively delivers innovative healthcare solutions to the region. By overseeing the alignment of local commercial activities with global corporate goals, the President (Taiwan) drives market penetration and growth. This role involves leading cross-functional teams to navigate the unique regulatory and competitive landscape of the region. Keizo Miyazawa maintains critical partnerships with local healthcare providers to ensure the successful adoption of new medications. Through the optimization of regional operations, the President (Taiwan) ensures that the company remains a leader in the pharmaceutical industry. This leadership position directly supports the global mission of the organization by expanding the reach of therapeutic solutions into key Asian markets, ultimately improving patient outcomes through localized strategic execution.

Prateek Gaur, the Chief of Staff, Medical Affairs at Novartis, coordinates strategic initiatives across the global medical research division. Gaur aligns clinical development priorities with the broader pharmaceutical manufacturing goals of the organization. By managing cross-functional workflows, the Chief of Staff, Medical Affairs ensures that scientific data reaches healthcare providers efficiently. This role involves synthesizing complex medical insights to support the development of innovative treatments. Prateek Gaur maintains rigorous standards for evidence-based communication, facilitating collaboration between research teams and commercial departments. Through the optimization of internal processes, the Chief of Staff, Medical Affairs drives operational excellence in North American and European research hubs. This leadership position directly impacts the speed at which new healthcare solutions reach patients, ultimately strengthening the market position of the company as a leader in pharmaceutical innovation.

Evelyn Messer, the Senior Meeting Planner, Chief Revenue Officer Management . at Novartis, architects high-level executive engagements that support global revenue growth. Messer manages the logistical framework for strategic summits, ensuring that the Chief Revenue Officer maintains alignment with international market objectives. By coordinating complex stakeholder interactions, the Senior Meeting Planner, Chief Revenue Officer Management . facilitates critical decision-making processes regarding pharmaceutical distribution. This role requires precise synchronization of global operations to ensure that revenue-generating initiatives receive necessary executive focus. Evelyn Messer optimizes the scheduling and resource allocation for leadership meetings, directly contributing to the efficiency of the commercial organization. Through the management of these high-stakes environments, the Senior Meeting Planner, Chief Revenue Officer Management . supports the overarching financial goals of the company, ensuring that leadership remains focused on expanding the reach of innovative healthcare solutions across diverse global regions.

Hisako Ohe, the Chief Marketing Officer & Senior Manager, Quality at Novartis, directs the global brand strategy while overseeing rigorous quality assurance protocols. Ohe integrates marketing initiatives with strict regulatory compliance to ensure that pharmaceutical messaging remains accurate and effective. By bridging the gap between commercial outreach and quality control, the Chief Marketing Officer & Senior Manager, Quality maintains the reputation of the company in competitive markets. This role involves analyzing consumer data to refine product positioning across Asia and other key territories. Hisako Ohe drives the implementation of quality management systems that support the delivery of safe, innovative medications. Through the alignment of marketing campaigns with internal quality standards, the Chief Marketing Officer & Senior Manager, Quality ensures that all promotional activities reflect the commitment of the organization to patient safety and therapeutic excellence, ultimately fostering long-term trust with healthcare providers.

Soukaïna Mouallif, the Customer Engagement Chief of Staff (US) at Novartis, manages the operational framework for patient and provider interactions within the North American market. Mouallif architects engagement strategies that enhance the visibility of pharmaceutical solutions among key medical stakeholders. By streamlining communication channels, the Customer Engagement Chief of Staff (US) ensures that commercial teams remain responsive to evolving healthcare needs. This role involves coordinating cross-departmental efforts to improve the overall customer experience. Soukaïna Mouallif drives the execution of engagement programs that support the adoption of innovative treatments. Through the analysis of market feedback, the Customer Engagement Chief of Staff (US) optimizes outreach efforts, ensuring that the company maintains a strong presence in the competitive US pharmaceutical landscape. This leadership function directly supports the growth of the organization by fostering deeper relationships with the medical community and improving patient access to essential medications.

Daniela Castaneda, the Immunology Director, Commercial Operations & Chief of Staff at Novartis, oversees the strategic development of immunology-focused commercial initiatives. Castaneda manages the operational infrastructure required to bring specialized treatments to market. By aligning commercial operations with clinical research milestones, the Immunology Director, Commercial Operations & Chief of Staff ensures that the company effectively addresses complex medical conditions. This role involves coordinating with global teams to scale the distribution of immunology products. Daniela Castaneda drives the implementation of efficient business processes that support the growth of the therapeutic portfolio. Through the integration of commercial strategy and operational management, the Immunology Director, Commercial Operations & Chief of Staff ensures that the organization remains at the forefront of immunological research. This leadership position directly impacts the ability of the company to deliver life-changing therapies to patients across international markets, maintaining a competitive edge in the pharmaceutical industry.

Rekha Garg, the Chief Medical Officer at Novartis, leads the global medical strategy and clinical oversight for the entire pharmaceutical portfolio. Garg architects the scientific vision that guides the development of innovative medications. By ensuring that all clinical trials and medical practices adhere to the highest safety and efficacy standards, the Chief Medical Officer maintains the reputation of the company as a trusted healthcare provider. This role involves collaborating with regulatory bodies and research institutions to advance the therapeutic pipeline. Rekha Garg drives the integration of medical insights into the commercial strategy, ensuring that products meet the actual needs of patients. Through the leadership of global medical teams, the Chief Medical Officer ensures that the organization remains at the cutting edge of scientific discovery. This position directly impacts the success of the company in delivering life-saving treatments to patients worldwide, reinforcing the commitment to medical excellence.